The temperature-controlled packaging market just got a significant consolidation boost, as Eutecma, backed by Great Point Partners, has completed its acquisition of TempAid. The move, which brings together complementary strengths in reusable and single-use shipping solutions, signals a broader push toward end-to-end cold chain coverage for pharmaceutical clients worldwide.
Health Business Group provided commercial due diligence for the transaction, expanding global end-to-end cold chain packaging capabilities.
Health Business Group's rigorous approach to primary and secondary research, and their ability to synthesize it into clear insights, made them a valuable partner on the TempAid investment.”— Eddie Hjerpe, Principal at Great Point Partners
Health Business Group, a boutique strategy consulting firm advising life sciences and healthcare investors, served as an advisor to Eutecma and its majority investor, Great Point Partners (GPP), in Eutecma's acquisition of TempAid. TempAid is a North American provider of validated temperature-controlled packaging for pharmaceutical, life sciences and healthcare organizations.
This deal effectively merges two distinct but complementary product lines. Eutecma brings its reusable, larger-format shipping systems, while TempAid contributes a robust portfolio of thermal packaging designed for parcel and last-mile delivery. Together, the combined entity will offer both reusable and single-use options—from individual mailers up to bulk pallet shippers—with operational reach spanning Europe, North America and Asia.
Health Business Group was tasked with conducting commercial due diligence on TempAid prior to the acquisition. That work involved a deep assessment of TempAid's market standing, its customer relationships, and the strength of its product portfolio, all weighed against how well it would mesh with Eutecma's existing operations in the global pharmaceutical cold chain.
The acquisition is not the first time Health Business Group has worked with these parties. It also advised on GPP's 2025 investment in Eutecma, which preceded this latest move.
“Health Business Group brought a strong understanding of the cold chain packaging space to this work,” said Eddie Hjerpe, Principal at Great Point Partners. “Their rigorous approach to primary and secondary research, and their ability to synthesize it into clear insights, made them a valuable partner on the TempAid investment.”
"TempAid has built a strong position in an attractive market for temperature-controlled packaging," said David E. Williams, President of Health Business Group. "Together, Eutecma and TempAid provide customers with one source for reusable and single-use solutions that cover the full journey, from pallet to parcel."
To learn more about Health Business Group's strategy consulting and diligence support for private equity firms and strategic acquirers, visit www.healthbusinessgroup.com.
About Health Business Group
Health Business Group is a boutique strategy consulting firm that helps clients in life sciences, technology-enabled healthcare services, and private equity develop and execute innovative business strategies. Founded in 2003, the firm is staffed by highly experienced consultants with particular expertise in due diligence for financial and strategic investors. Learn more at www.HealthBusinessGroup.com.
About Eutecma
Founded in 2008 in Mannheim, Germany, Eutecma designs and manufactures sustainable, reusable temperature-controlled packaging for the global pharmaceutical industry. Its modular systems are engineered for multiple shipping cycles, and its retecma program and international Refreshment Centers refurbish or recycle used packaging to support a circular model. Learn more at www.eutecma.com.
About TempAid
TempAid Corporation develops and manufactures temperature-controlled packaging for pharmaceutical, life sciences and healthcare organizations. Its portfolio includes SpeedyPac mailers, SteadyPac thermal shippers, gel packs and PCM mats. The company is supported by in-house R&D and ISTA-certified thermal testing, and it has manufacturing in North America and Asia. Learn more at www.tempaid.com.
About Great Point Partners
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a health care investment firm with 30 professionals, investing in the United States, Canada, and Europe. GPP manages approximately $1.7 billion of capital (including committed and uncalled capital) in its private funds and public life sciences equity strategy. GPP has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. Learn more at www.gppfunds.com.
David Williams
Health Business Group
+1 617-671-8810
Why it matters: This acquisition consolidates two key players in a niche but critical segment of pharmaceutical logistics, where maintaining precise temperatures during transport is non-negotiable. By uniting reusable and single-use packaging under one roof, the combined company is better positioned to serve a global customer base demanding both flexibility and reliability in cold chain management.
